Guanidino compounds as regulators of nitric oxide synthase
    1.
    发明授权
    Guanidino compounds as regulators of nitric oxide synthase 失效
    胍基化合物作为一氧化氮合酶的调节剂

    公开(公告)号:US5478946A

    公开(公告)日:1995-12-26

    申请号:US159409

    申请日:1993-11-30

    摘要: Compounds of the formula: ##STR1## useful as regulators of nitric oxide synthase that indirectly modulate cyclic guanosine monophosphate (cGMP), pharmaceutical compositions thereof, for treating disorders of vascular smooth muscles, macrophages, neurons, platelets, bronchial smooth muscles, optic muscles and gastrointestinal smooth muscles, sickle cell anemia and diabetes.

    摘要翻译: 用于作为间接调节环鸟苷酸(cGMP)的一氧化氮合成酶的调节剂的下式的化合物,其用于治疗血管平滑肌,巨噬细胞,神经元,血小板,支气管平滑肌等疾病的药物组合物, 视神经肌肉和胃肠道平滑肌,镰状细胞性贫血和糖尿病。

    Derivatives of D-glutamic acid and D-aspartic acid
    5.
    发明授权
    Derivatives of D-glutamic acid and D-aspartic acid 失效
    D-谷氨酸和D-天冬氨酸的衍生物

    公开(公告)号:US5128346A

    公开(公告)日:1992-07-07

    申请号:US571945

    申请日:1990-08-23

    摘要: A compound of the formula: ##STR1## wherein R.sub.1 and R.sub.2 are substituents; R.sub.6 is hydrogen, loweralkyl, cycloalkyl, loweralkenyl, arylalkyl, (substituted aryl)alkyl, or (heterocyclic)alkyl; B is a bond, an alkylene group, an alkenylene group, an alkadienylene group or a heteroatom containing linking group; D is a substituted acyl group or tetrazolyl; Z is CO, C(S) or S(O).sub.2 ; Ar is a heterocyclic group; and n is 1 to 3.Also disclosed are a composition and a method for antagonizing CCK, a composition and method for treating or preventing gastrointestinal, central nervous, appetite regulating and pain regulating systems, a composition and method for treating or preventing hyperinsulinemia, methods of making the compounds and intermediates useful in making the compounds.

    摘要翻译: 下式的化合物:其中R1和R2是取代基; R6是氢,低级烷基,环烷基,低级烯基,芳基烷基,(取代的芳基)烷基或(杂环)烷基; B是键,亚烷基,亚烯基,亚二烯基或含杂原子的连接基团; D是取代的酰基或四唑基; Z是CO,C(S)或S(O)2; Ar是杂环基; 还公开了拮抗CCK的组合物和方法,治疗或预防胃肠,中枢神经,食欲调节和疼痛调节系统的组合物和方法,治疗或预防高胰岛素血症的组合物和方法,方法 使得化合物和中间体可用于制备化合物。